Affordable pricing, personalized treatment
When to Contact Your Provider Reach out if you experience severe, persistent vomiting that prevents adequate hydration, severe abdominal pain that doesnt resolve, signs of pancreatitis (severe upper abdominal pain radiating to your back), significant changes in vision, symptoms of gallbladder problems (pain in upper right abdomen), or side effects that dont improve after three weeks at a dose
Once reconstituted for experimental use, aliquots should be kept at 4C and used within a short timeframe in accordance with standard peptide handling protocols
Start your intake Understanding the FDA-Approved Dosing Pathway The FDA-approved dosing schedule for semaglutide (Wegovy) follows a 16-week titration protocol: weeks 1-4 at 0.25 mg, weeks 5-8 at 0.5 mg, weeks 9-12 at 1 mg, weeks 13-16 at 1.7 mg, then maintenance at 2.4 mg